Eradication Rate and Factors Influencing Helicobacter pylori Infection Clearance Using Standard Triple Therapy at a Single Centre in Jazan Region, Saudi Arabia: A Retrospective Study
DOI: https://doi.org/10.2147/ijgm.s456865
IF: 2.145
2024-06-05
International Journal of General Medicine
Abstract:Majid Ahmed Darraj 1– 3 1 Department of Internal Medicine, Faculty of Medicine, Jazan University, Jazan, Saudi Arabia; 2 Department of internal medicine, King Fahad Central Hospital, Jazan, Saudi Arabia; 3 Department of Internal Medicine, Al-Hayat Jazan Hospital, Jazan, Saudi Arabia Correspondence: Majid Ahmed Darraj, Email Introduction: Helicobacter pylori infection is a common gastrointestinal infection that affects around 50% of the global population. This infection can lead to various health conditions such as peptic ulcer disease, dyspepsia, gastric carcinoma, and mucosa-associated lymphoid tissue lymphoma. The triple therapy which consists of proton-pump inhibitors, clarithromycin, and amoxicillin or metronidazole for 14 days is considered the first-line treatment for H. pylori and its eradication, especially in areas where clarithromycin sensitivity is still high. However, recent research shows that the efficacy of this treatment is decreasing due to antibiotic resistance. Methods: This was a retrospective study that took place at Al-Hayat Jazan Hospital in Jazan, Saudi Arabia. The study analyzed the medical records of 186 patients with H. pylori who had undergone the standard triple therapy. The objectives of this study were to determine the eradication rate of H. pylori by using the standard triple therapy, and to highlight the influence of some demographic characteristics such as age, gender, diabetes mellitus, and smoking on the eradication rate, in Jazan region, Saudi Arabia. Results: The medical records of 186 patients were included in the study. The overall rate of successful eradication was found to be 77.4%. The results of the study showed that the decline in the eradication rate was significantly associated with the presence of diabetes and smoking status (with p-values of < 0.001 and < 0.004, respectively). Conclusion: This study finds that the standard triple therapy for H. pylori eradication is less effective than optimal standards, as per literature and guidelines. Given its declining efficacy globally, alternative first-line treatments may be necessary. Further research is needed to assess its effectiveness in various regional contexts. Keywords: Helicobacter pylori, H. pylori , triple therapy, eradication rates, Jazan region Helicobacter pylori ( H. pylori ) is a Gram-negative bacillus that causes gastrointestinal diseases, such as peptic ulcer and carcinoma of the stomach. It is also linked with mucosa-associated lymphoid tissue (MALT) lymphoma, vitamin B 12 deficiency, iron deficiency anemia, and idiopathic thrombocytopenic purpura (ITP). 1 H. pylori infection is considered one of the most common infections worldwide, and contaminated water is considered the main source of infection, especially in developing countries. 2 Other risk factors include individuals with low socioeconomic status and a family history of the infection. 2 H. pylori prevalence differs throughout the world with a prevalence of 30% in the United States in contrast to 70 to 80% in South America. 3 The data from Arab countries reported higher prevalence, which approaches for example 78% in the United Arab Emirates. 4 H. pylori frequency is higher (approaching 80%) in developing countries rather than in developed ones. 1 In Saudi Arabia, the prevalence of H. pylori infection has notable variation rates ranging from 10.2% to 96% in the various geographical locations of the country. 5,6 One study reported a prevalence of 46.5% in Jazan province. 7 A study conducted in Jazan by Akeel et al reported that H. pylori virulence genes are extremely common and diversified in patients with dyspepsia in southwest Saudi Arabia. 6 It is important for patients with a history of peptic ulcers, especially those with MALT lymphoma, and those who have undergone endoscopic resection for early gastric cancer, to be screened for H. pylori . 8 H. pylori screening is also recommended for patients with atypical presentation of GERD, long-term aspirin and NSAID use, uninvestigated and functional dyspepsia, unexplained iron deficiency anemia, and ITP. 9 If the result of screening is positive, treatment for the eradication of H. pylori should be initiated. Prior use of antibiotics should also be taken into consideration when selecting a management strategy. 2,10 Gastric and duodenal ulcers are mainly caused by H. pylori , NSAIDs, or a combination of both, and treating H. pylori is an effective way to decrease the recurrence risk of ulcers -Abstract Truncated-
medicine, general & internal